menu
    • menu

    Company profile for Tourmaline Bio

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Tourmaline is a late-stage clinical biotechnology company driven by our mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. In doing so, we seek to develop assets and medicines that have the potential to establish new standards of care in areas of high unmet medical need. The company offers medicines for life-altering immune diseases, enabling professi...
    Tourmaline is a late-stage clinical biotechnology company driven by our mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. In doing so, we seek to develop assets and medicines that have the potential to establish new standards of care in areas of high unmet medical need. The company offers medicines for life-altering immune diseases, enabling professionals to cure patients.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Tourmaline BioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    27 West 24th Street, Suite 702 New York, New York 10010
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.tourmalinebio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/tourmaline-bio/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Novartis Completes Acquisition Of Tourmaline Bio
    Novartis Completes Acquisition Of Tourmaline Bio

    28 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/28/3175578/0/en/Novartis-completes-acquisition-of-Tourmaline-Bio.html

    GLOBENEWSWIRE
    28 Oct 2025
    Share Share
    Novartis Announces Expiration Of Tourmaline Bio Tender Offer
    Novartis Announces Expiration Of Tourmaline Bio Tender Offer

    28 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/28/3175099/0/en/Novartis-announces-expiration-of-Tourmaline-Bio-tender-offer.html

    GLOBENEWSWIRE
    28 Oct 2025
    Share Share
    Novartis Completes Hart-Scott-Rodino Waiting Period
    Novartis Completes Hart-Scott-Rodino Waiting Period

    22 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/22/3170793/0/en/Novartis-announces-expiration-of-Hart-Scott-Rodino-waiting-period-of-Tourmaline-Bio-tender-offer.html

    GLOBENEWSWIRE
    22 Oct 2025
    Share Share
    Novartis Initiates Tender Offer For Tourmaline Bio Acquisition
    Novartis Initiates Tender Offer For Tourmaline Bio Acquisition

    29 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/29/3157623/0/en/Novartis-announces-commencement-of-tender-offer-to-acquire-Tourmaline-Bio.html

    GLOBENEWSWIRE
    29 Sep 2025
    Share Share
    Novartis to Acquire Tourmaline Bio for $1.4 Billion
    Novartis to Acquire Tourmaline Bio for $1.4 Billion

    09 Sep 2025

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/novartis-acquire-tourmaline-bio-14-billion-2025-09-09/

    REUTERS
    09 Sep 2025
    Share Share
    Tourmaline Bio Unveils Phase 2 TRANQUILITY Trial Data at 2025
    Tourmaline Bio Unveils Phase 2 TRANQUILITY Trial Data at 2025

    31 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/31/3141921/0/en/Tourmaline-Bio-Presents-Data-from-the-Ongoing-Phase-2-TRANQUILITY-Trial-at-the-2025-European-Society-of-Cardiology-Congress.html

    GLOBENEWSWIRE
    31 Aug 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search